Skip to main content
. 2017 Jun 16;8(57):96945–96957. doi: 10.18632/oncotarget.18547

Table 2. Correlations of CALR and PDIA3 expressions with clinicopathological parameters of patients with NSCLC.

CALR PDIA3
Parameters n Low High P Low High P
(n = 25) (n = 63) (n = 33) (n = 55)
Gender
 Male 46 12 34 0.613 20 26 0.225
 Female 42 13 29 13 29
Age (years)
 ≥ 62 44 13 31 0.813 14 30 0.271
 < 62 44 12 32 19 25
Tumor sizes (cm)
 ≤ 3 33 7 26 0.246 10 23 0.280
 > 3 55 18 37 23 32
Lymph node metastases
 0 37 13 24 0.233 12 25 0.403
 ≥ 1 51 12 39 21 30
AJCC stages
 I 27 8 19 0.866 8 19 0.310
 II + III 61 17 44 25 36
Pathological grades
 I + I–II + II 62 19 43 0.473 25 37 0.398
 II–III + III 26 6 20 8 18

Cases of group “–” and “+” were assigned to group low. Cases of group “++” and “+++” were assigned to group high.